-
HyperScribe T7 High Yield RNA Synthesis Kit
2026-09-15
The HyperScribe T7 High Yield RNA Synthesis Kit is an in vitro transcription RNA kit for high-yield T7 RNA polymerase transcription. The K1047 format supports research workflows involving modified, capped, dye-labeled, or biotinylated RNA, with a reported yield of up to approximately 50 μg per 20 μL reaction.
-
GLP-1 (9-36) Amide: A Causal Assay Framework
2026-09-15
GLP-1 (9-36) amide can do more than block a receptor: it can help researchers distinguish GLP-1 receptor-dependent signaling from ligand crosstalk and assay artifacts. This guide translates high-throughput cAMP findings into a rigorous workflow for GLP-1 receptor signaling research and metabolic studies.
-
SMYD2–miR-125b Signaling in RCC Drug Resistance
2026-09-14
The reference study identifies SMYD2 as an adverse prognostic factor and mechanistic driver of clear cell renal cell carcinoma through regulation of the miR-125b/DKK3 axis. Its integrated clinical, molecular, cellular, and xenograft evidence also connects SMYD2 inhibition with reduced P-glycoprotein activity and improved sensitivity to several anticancer drugs, including fluorouracil.
-
RITA (NSC 652287): Reliable Assay Design
2026-09-14
Learn how RITA (NSC 652287), SKU A4202, can support better-designed viability, proliferation, and cytotoxicity studies. This scenario-based guide connects its nanomolar activity and formulation requirements with practical assay controls, readout interpretation, and vendor-selection criteria.
-
nor-NOHA Workflows for Arginase and AML Research
2026-09-13
Build mechanism-aware assays around reversible arginase inhibition, from HepG2 apoptosis and invasion studies to AML immunometabolism. This guide connects nor-NOHA acetate with CD36-driven immune escape while separating evidence-backed findings from practical assay recommendations.
-
Glutathione Redox Signals in Hypoxic Tumors
2026-09-12
Hypoxia and immunometabolic competition reshape the tumor microenvironment, but mechanistic models need quantitative redox evidence. This thought-leadership article explains how paired GSH and GSSG measurements can strengthen studies of hypoxic tumors, immune dysfunction, and translational biomarker development. It connects the findings of a recent Cancer Letters review with practical assay strategy and positions the GSH and GSSG Assay Kit as a focused tool for reduced glutathione detection, oxidized glutathione measurement, and redox state analysis across relevant biological matrices.
-
Cyclopamine: Hedgehog Signaling Workflows
2026-09-12
Cyclopamine is a practical Smoothened-directed tool for separating Hedgehog pathway effects from downstream cell and tissue phenotypes. This guide connects cancer-cell assays with comparative genital-tubercle development studies, emphasizing dosing, controls, readouts, and troubleshooting.
-
Fluorouracil Assay Design for Solid Tumor Models
2026-09-11
Build reproducible 5-Fluorouracil workflows around thymidylate synthase inhibition, DNA-replication stress, and orthogonal cell-death readouts. This guide also shows how to use Fluorouracil as a cytotoxic benchmark when evaluating Wnt/β-catenin–directed strategies in colon cancer research, while keeping combination claims experimentally grounded.
-
ECL Chemiluminescent Substrate Detection Kit Workflow
2026-09-11
Build a reproducible HRP-based workflow for protein-level evidence in radiation and ferroptosis studies. This practical guide connects ECL detection with DHODH, ACSL4, and GPX4 analysis while emphasizing exposure control, assay boundaries, and troubleshooting.
-
Bestatin and Actinonin: Intracellular Action
2026-09-10
The reference study used matched antiproliferative and aminopeptidase assays, together with drug-efflux modifiers, to show that bestatin and actinonin act predominantly through intracellular mechanisms rather than cell-surface aminopeptidase inhibition alone. Its transporter-focused design provides a useful framework for interpreting inhibitor accumulation, apparent resistance, and pharmacological interactions in hematologic cancer models.
-
2-Deoxy-D-glucose and Lactylation-Aware Assays
2026-09-10
2-Deoxy-D-glucose is more than a glycolysis inhibitor: it can help position metabolic stress within lactate-linked epigenetic pathways. This article connects 2-DG assay design with the H3K18 lactylation–METTL5–CCT2 axis while defining practical boundaries for cancer and antiviral research.
-
CD36-Driven Immune Escape in AML
2026-09-09
A 2024 Cell Reports Medicine study identifies a non-canonical CD36 program in which oxidized LDL and palmitate activate innate immune signaling in AML cells and suppress antitumor T-cell responses. The work connects lipid availability and decitabine resistance, while showing that statin-mediated lipid restriction can improve decitabine efficacy in preclinical models.
-
Cyclic di-GMP as an Antitoxin in Biofilm Persistence
2026-09-09
Liao et al. identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. The study links adhesion-stage signaling to DNA double-strand breaks, genome instability, and antibiotic-persistent cells, providing a mechanistic framework for biofilm formation regulation beyond simple diffusion or nutrient-limitation models.
-
AMPK–SQSTM1 Feedback in Metabolic Stress
2026-09-08
The reference study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that coordinates NRF2 activation with energy-stress adaptation during metabolic stress. Its mechanistic framework links lysosomal pH, calcium release, ROS, TFEB/TFE3, and KEAP1 degradation, while defining experimental boundaries for translating these findings to sensory and pain-related research.
-
Dacarbazine Workflows for Cancer Drug-Response Assays
2026-09-08
Build more informative Dacarbazine assays by separating growth inhibition from true cell killing, rather than relying on a single viability endpoint. This practical guide covers fresh-solution handling, time-resolved screening, comparative oncology models, and troubleshooting for melanoma, lymphoma, and sarcoma research.